Clinitech Laboratory Ltd vs Kk Shah Hospitals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Clinitech Laboratory Ltd is ₹ 32 as of 07 Oct 15:30 . The P/E Ratio of Clinitech Laboratory Ltd is 23.3 as of March 2025 .The P/E Ratio of KK Shah Hospitals Ltd is 0 as of March 2025 . The Market Cap of Clinitech Laboratory Ltd is ₹ 9.18 crore as of March 2025 .The Market Cap of KK Shah Hospitals Ltd is ₹ 0 crore as of March 2025 . The Dividend Payout of Clinitech Laboratory Ltd changed from 0 % on February 2023 to 0 % on March 2022 . This represents a CAGR of 0.0% over 7 yearsThe Dividend Payout of KK Shah Hospitals Ltd changed from 55.82 % on March 2024 to 0 % on March 2022 . This represents a CAGR of -100.00% over 5 years .

About Clinitech Laboratory Ltd

Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai.
The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai.
Company is in the business of healthcare services providing superior quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc. The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018.
Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests.

About KK Shah Hospitals Ltd

KK Shah Hospitals Limited was incorporated under the name style of 'Jeevan Parv Healthcare Limited' on August 25, 2022 by the Central Registration Center, Manesar.
Subsequently, the Company changed its name from 'Jeevan Parv Healthcare Limited' to 'KK Shah Hospitals Limited' and a fresh certificate of incorporation on November 30, 2022 was issued by the Registrar of Companies, Gwalior, Madhya Pradesh.
The Company is engaged in the providing healthcare services. The Promoter, Dr. Kirti Kumar Shah started a clinic in Ratlam city in the year 1976 which further was transformed into a nursing home in the year 1991.
Subsequently, Dr. Kirti Kumar Shah established pediatrics care unit in 1991 under the name of 'Shah Maternity and Nursing Home'.
He started paediatric unit having Neonatal Intensive Care Unit (NICU) as an integral part of the Clinic in 1994.

FAQs for the comparison of Clinitech Laboratory Ltd and KK Shah Hospitals Ltd

Which company has a larger market capitalization, Clinitech Laboratory Ltd or KK Shah Hospitals Ltd?

Market cap of Clinitech Laboratory Ltd is 7 Cr while Market cap of KK Shah Hospitals Ltd is 30 Cr

What are the key factors driving the stock performance of Clinitech Laboratory Ltd and KK Shah Hospitals Ltd?

The stock performance of Clinitech Laboratory Ltd and KK Shah Hospitals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Clinitech Laboratory Ltd and KK Shah Hospitals Ltd?

As of October 25, 2026, the Clinitech Laboratory Ltd stock price is INR ₹32.0. On the other hand, KK Shah Hospitals Ltd stock price is INR ₹45.0.

How do dividend payouts of Clinitech Laboratory Ltd and KK Shah Hospitals Ltd compare?

To compare the dividend payouts of Clinitech Laboratory Ltd and KK Shah Hospitals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.